Table 5.
Virus | Neuroinvasivenessa (log10 PFU) | Neurovirulenceb (log10 PFU) | Phenotypee | |||
---|---|---|---|---|---|---|
LD50c | ID50d | LD50 | ID50 | Neuroinvasive | Neurovirulent | |
JCV/61/CO | 4.8 | 0.8 | 1.2 | 0.5 | Low | High |
JCV/61/CO-cl | > 4 | 0.9 | 0.4 | 0.4 | Low | High |
JCV/03/CT | > 5 | < 0 | 3.7 | 0.3 | Low | Low |
JCV/03/CT-cl | > 5 | < 0 | > 4 | -0.5 | Low | Low |
JCV/04/CT-cl | > 5 | 0.3 | 1.4 | < -1 | Low | High |
a Groups of weanling Swiss Webster mice (21-23 days old) were inoculated intraperitoneally with 100 μL of diluted virus (0 - 5 log10 PFU).
b Groups of six weanling Swiss Webster mice (21-23 days old) were inoculated intracerebrally with 10 μL of diluted virus (-1 - 4 log10 PFU).
c LD50 = Lethal dose 50%.
d ID50 = Infectious dose 50%. Infection was defined by the development of clinical disease and/or a four-fold increase in neutralizing antibody titers.
e Neuroinvasive phenotype: Low = LD50 > 3.5 log10 PFU. Neurovirulent phenotype: Low = LD50 > 3.5 log10 PFU; High = LD50 < 1.5 log10 PFU.